Globitair

Bombardments

After capital-markets day flop, Novo strikes licensing deal that sends a Swedish company’s stock soaring

MarketWatchSweden

Just days after a capital-markets day left investors wondering what’s next for Novo Nordisk, the Danish drug giant struck a licensing deal worth over $1 billion.

Read the full story at MarketWatchOpen in the live monitor

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More news about Sweden

More on Bombardments